Sven Ansorge

1.2k total citations
33 papers, 897 citations indexed

About

Sven Ansorge is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Sven Ansorge has authored 33 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Genetics and 12 papers in Infectious Diseases. Recurrent topics in Sven Ansorge's work include Viral Infectious Diseases and Gene Expression in Insects (24 papers), Virus-based gene therapy research (19 papers) and Viral gastroenteritis research and epidemiology (11 papers). Sven Ansorge is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (24 papers), Virus-based gene therapy research (19 papers) and Viral gastroenteritis research and epidemiology (11 papers). Sven Ansorge collaborates with scholars based in Canada, France and Switzerland. Sven Ansorge's co-authors include Amine Kamen, Olivier Henry, Stéphane Lanthier, Georg H. Schmid, Julia Transfiguracion, Yves Durocher, Danielle Jacob, Rénald Gilbert, Emma Petiot and Parminder S. Chahal and has published in prestigious journals such as PLoS ONE, Scientific Reports and Vaccine.

In The Last Decade

Sven Ansorge

33 papers receiving 872 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sven Ansorge Canada 19 695 431 217 141 122 33 897
Julia Transfiguracion Canada 14 478 0.7× 362 0.8× 145 0.7× 101 0.7× 74 0.6× 18 615
Stéphane Lanthier Canada 13 428 0.6× 294 0.7× 112 0.5× 108 0.8× 55 0.5× 16 548
Danielle Jacob Canada 13 474 0.7× 341 0.8× 151 0.7× 112 0.8× 101 0.8× 16 585
Emma Petiot France 15 364 0.5× 142 0.3× 121 0.6× 39 0.3× 131 1.1× 31 584
Lukkana Suksanpaisan United States 16 186 0.3× 302 0.7× 252 1.2× 158 1.1× 108 0.9× 34 724
Jörn Stitz Germany 16 393 0.6× 384 0.9× 120 0.6× 84 0.6× 100 0.8× 42 650
Robert Morenweiser Germany 9 374 0.5× 255 0.6× 123 0.6× 61 0.4× 85 0.7× 9 541
Gilles St‐Laurent Canada 15 368 0.5× 226 0.5× 124 0.6× 76 0.5× 25 0.2× 24 623
Magda Marquet France 12 583 0.8× 309 0.7× 107 0.5× 70 0.5× 73 0.6× 16 875
Mark S. Drinker United States 5 529 0.8× 189 0.4× 123 0.6× 121 0.9× 91 0.7× 5 847

Countries citing papers authored by Sven Ansorge

Since Specialization
Citations

This map shows the geographic impact of Sven Ansorge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven Ansorge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven Ansorge more than expected).

Fields of papers citing papers by Sven Ansorge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven Ansorge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven Ansorge. The network helps show where Sven Ansorge may publish in the future.

Co-authorship network of co-authors of Sven Ansorge

This figure shows the co-authorship network connecting the top 25 collaborators of Sven Ansorge. A scholar is included among the top collaborators of Sven Ansorge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven Ansorge. Sven Ansorge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Chun Fang, Sonia Tremblay, Sophie Broussau, et al.. (2022). Culture media selection and feeding strategy for high titer production of a lentiviral vector by stable producer clones cultivated at high cell density. Bioprocess and Biosystems Engineering. 45(8). 1267–1280. 5 indexed citations
2.
Sharon, David, et al.. (2020). A pooled genome-wide screening strategy to identify and rank influenza host restriction factors in cell-based vaccine production platforms. Scientific Reports. 10(1). 12166–12166. 19 indexed citations
3.
Gélinas, Jean‐François, Hiva Azizi, Sascha Kießlich, et al.. (2019). Production of rVSV-ZEBOV in serum-free suspension culture of HEK 293SF cells. Vaccine. 37(44). 6624–6632. 26 indexed citations
4.
Brochu, Denis, Michel Gilbert, Pascal Perrier, et al.. (2019). Assessment of fed-batch cultivation strategies for an inducible CHO cell line. Journal of Biotechnology. 298. 45–56. 9 indexed citations
5.
Fulton, Kelly M., Susan M. Twine, Parminder S. Chahal, et al.. (2019). Characterization of influenza H1N1 Gag virus-like particles and extracellular vesicles co-produced in HEK-293SF. Vaccine. 37(47). 7100–7107. 24 indexed citations
6.
Brochu, Denis, Michel Gilbert, Pascal Perrier, et al.. (2019). Process intensification for the production of rituximab by an inducible CHO cell line. Bioprocess and Biosystems Engineering. 42(5). 711–725. 16 indexed citations
7.
Shen, Chun Fang, Claire Guilbault, Xiuling Li, et al.. (2019). Development of suspension adapted Vero cell culture process technology for production of viral vaccines. Vaccine. 37(47). 6996–7002. 46 indexed citations
8.
Julien, Thomas, Johnny Montes, Sven Ansorge, et al.. (2017). Accelerated mass production of influenza virus seed stocks in HEK-293 suspension cell cultures by reverse genetics. Vaccine. 35(26). 3423–3430. 13 indexed citations
9.
Zou, Wei, Anne Marcil, Eric Paquet, et al.. (2017). Generation of monoclonal pan-hemagglutinin antibodies for the quantification of multiple strains of influenza. PLoS ONE. 12(6). e0180314–e0180314. 8 indexed citations
10.
Kim, Howard S., Stéphane Lanthier, Alice Bernier, et al.. (2017). Scalable Lentiviral Vector Production Using Stable HEK293SF Producer Cell Lines. Human Gene Therapy Methods. 28(6). 330–339. 83 indexed citations
11.
Petiot, Emma, Sven Ansorge, Manuel Rosa‐Calatrava, & Amine Kamen. (2016). Critical phases of viral production processes monitored by capacitance. Journal of Biotechnology. 242. 19–29. 21 indexed citations
12.
Gilbert, Rénald, Antoine W. Caron, Parminder S. Chahal, et al.. (2016). Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate. Vaccine. 34(29). 3371–3380. 50 indexed citations
13.
Swiech, Kamilla, Amine Kamen, Sven Ansorge, et al.. (2011). Transient transfection of serum-free suspension HEK 293 cell culture for efficient production of human rFVIII. BMC Biotechnology. 11(1). 114–114. 28 indexed citations
14.
Petiot, Emma, Danielle Jacob, Stéphane Lanthier, et al.. (2011). Metabolic and Kinetic analyses of influenza production in perfusion HEK293 cell culture. BMC Biotechnology. 11(1). 84–84. 60 indexed citations
15.
16.
Jacob, Danielle, et al.. (2010). Scalable production of influenza virus in HEK-293 cells for efficient vaccine manufacturing. Vaccine. 28(21). 3661–3671. 93 indexed citations
17.
Segura, María Mercedes, Alain Garnier, Yves Durocher, Sven Ansorge, & Amine Kamen. (2009). New Protocol for Lentiviral Vector Mass Production. Methods in molecular biology. 614. 39–52. 32 indexed citations
18.
19.
Ansorge, Sven, Olivier Henry, & Amine Kamen. (2009). Recent progress in lentiviral vector mass production. Biochemical Engineering Journal. 48(3). 362–377. 25 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia Transfiguracion Breakdown of academic impact, for papers by Stéphane Lanthier Breakdown of academic impact, for papers by Danielle Jacob Breakdown of academic impact, for papers by Emma Petiot Breakdown of academic impact, for papers by Lukkana Suksanpaisan Breakdown of academic impact, for papers by Jörn Stitz Breakdown of academic impact, for papers by Robert Morenweiser Breakdown of academic impact, for papers by Gilles St‐Laurent Breakdown of academic impact, for papers by Magda Marquet Breakdown of academic impact, for papers by Mark S. Drinker
Rankless by CCL
2026